Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 532

    1.

    INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study.

    Cooper-DeHoff RM, Handberg EM, Mancia G, Zhou Q, Champion A, Legler UF, Pepine CJ.

    Expert Rev Cardiovasc Ther. 2009 Nov;7(11):1329-40.PMID: 19900016 [PubMed - in process]Related articles

    2.

    Comorbid depression and anxiety symptoms as predictors of cardiovascular events: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE) study.

    Rutledge T, Linke SE, Krantz DS, Johnson BD, Bittner V, Eastwood JA, Eteiba W, Pepine CJ, Vaccarino V, Francis J, Vido DA, Merz CN.

    Psychosom Med. 2009 Nov;71(9):958-64. Epub 2009 Oct 15.PMID: 19834049 [PubMed - in process]Related articles

    3.

    Systolic Blood Pressure and Subjective Well-Being in Patients with Coronary Artery Disease.

    Gong Y, Handberg EM, Gerhard T, Cooper-Dehoff RM, Ried LD, Johnson JA, Pepine CJ; for the INVEST Investigators.

    Clin Cardiol. 2009 Aug 26:1-7. [Epub ahead of print]PMID: 19711440 [PubMed - as supplied by publisher]Related articles

    4.

    Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).

    Merz CN, Johnson BD, Berga SL, Braunstein GD, Azziz R, Yang Y, Reis SE, Bittner V, Hodgson TK, Pepine CJ, Sharaf BL, Sopko G, Kelsey SF; Women's Ischemia Syndrome Evaluation Study Group.

    J Womens Health (Larchmt). 2009 Sep;18(9):1315-22.PMID: 19702477 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction.

    Traverse JH, Henry TD, Vaughn DE, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Piller LB, Penn MS, Byrne BJ, Perin EC, Gee AP, Hatzopoulos AK, McKenna DH, Forder JR, Taylor DA, Cogle CR, Olson RE, Jorgenson BC, Sayre SL, Vojvodic RW, Gordon DJ, Skarlatos SI, Moye' LA, Simari RD; Cardiovascular Cell Therapy Research Network (CCTRN).

    Am Heart J. 2009 Sep;158(3):356-63. Epub 2009 Jul 23.PMID: 19699857 [PubMed - indexed for MEDLINE]Related articles

    6.

    Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the national heart, lung, and blood institute-sponsored women's ischemia syndrome evaluation.

    Arant CB, Wessel TR, Ridker PM, Olson MB, Reis SE, Delia Johnson B, Sharaf BL, Pauly DF, Handberg E, Zineh I, Sopko G, Kelsey SF, Noel Bairey Merz C, Pepine CJ.

    Clin Cardiol. 2009 May;32(5):244-50.PMID: 19452486 [PubMed - in process]Related articles

    7.

    Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project.

    Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, Handberg EM, Zineh I, Kelsey SF, Arnsdorf MF, Black HR, Pepine CJ, Merz CN.

    Arch Intern Med. 2009 May 11;169(9):843-50.PMID: 19433695 [PubMed - indexed for MEDLINE]Related articles

    8.

    The potential role of nitric oxide in cardiovascular safety when treating patients with osteoarthritis and hypertension: a moderated panel discussion.

    White WB, Pepine CJ, Weber MA.

    Am J Med. 2009 May;122(5 Suppl):S23-5. No abstract available. PMID: 19393823 [PubMed - indexed for MEDLINE]Related articles

    9.

    The impact of nitric oxide in cardiovascular medicine: untapped potential utility.

    Pepine CJ.

    Am J Med. 2009 May;122(5 Suppl):S10-5. Review.PMID: 19393821 [PubMed - indexed for MEDLINE]Related articles

    10.

    Genetic and pharmacogenetic associations between NOS3 polymorphisms, blood pressure, and cardiovascular events in hypertension.

    Pacanowski MA, Zineh I, Cooper-Dehoff RM, Pepine CJ, Johnson JA.

    Am J Hypertens. 2009 Jul;22(7):748-53. Epub 2009 Apr 30.PMID: 19407804 [PubMed - indexed for MEDLINE]Related articles

    11.

    Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.

    Bangalore S, Messerli FH, Franklin SS, Mancia G, Champion A, Pepine CJ.

    Eur Heart J. 2009 Jun;30(11):1395-401. Epub 2009 Apr 7.PMID: 19351690 [PubMed - indexed for MEDLINE]Related articles

    12.

    Characteristics and outcomes of revascularized patients with hypertension: an international verapamil SR-trandolapril substudy.

    Denardo SJ, Messerli FH, Gaxiola E, Aranda JM Jr, Cooper-Dehoff RM, Handberg EM, Gong Y, Champion A, Zhou Q, Pepine CJ.

    Hypertension. 2009 Apr;53(4):624-30. Epub 2009 Feb 23.PMID: 19237684 [PubMed - indexed for MEDLINE]Related articles

    13.

    Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum.

    Cooper-DeHoff RM, Pacanowski MA, Pepine CJ.

    J Am Coll Cardiol. 2009 Feb 3;53(5 Suppl):S28-34. Review.PMID: 19179214 [PubMed - indexed for MEDLINE]Related articles

    14.

    Insulin as a cardiovascular therapeutic: improving glycemic control in patients with coronary artery disease.

    Pepine CJ.

    J Am Coll Cardiol. 2009 Feb 3;53(5 Suppl):S1-2. No abstract available. PMID: 19179211 [PubMed - indexed for MEDLINE]Related articles

    15.

    Efficacy and safety of ABT-335 (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidemia: a phase 3, randomized, controlled study.

    Mohiuddin SM, Pepine CJ, Kelly MT, Buttler SM, Setze CM, Sleep DJ, Stolzenbach JC.

    Am Heart J. 2009 Jan;157(1):195-203. Epub 2008 Nov 20.PMID: 19081418 [PubMed - indexed for MEDLINE]Related articles

    16.

    Promoter polymorphisms in ACE (angiotensin I-converting enzyme) associated with clinical outcomes in hypertension.

    Johnson AD, Gong Y, Wang D, Langaee TY, Shin J, Cooper-Dehoff RM, Schork NJ, Binkley P, Pepine CJ, Johnson JA, Sadee W.

    Clin Pharmacol Ther. 2009 Jan;85(1):36-44. Epub 2008 Oct 22.PMID: 18946466 [PubMed - indexed for MEDLINE]Related articles

    17.

    Pulse pressure and adverse outcomes in women: a report from the Women's Ischemia Syndrome Evaluation (WISE).

    Anderson RD, Sizemore BC, Barrow GM, Johnson BD, Merz CN, Sopko G, von Mering GO, Handberg EM, Nichols WW, Pepine CJ.

    Am J Hypertens. 2008 Nov;21(11):1224-30. Epub 2008 Sep 18.PMID: 18802432 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected myocardial ischemia. Results from the National Institutes of Health, National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).

    Shaw LJ, Merz CN, Bittner V, Kip K, Johnson BD, Reis SE, Kelsey SF, Olson M, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Sopko G, Pepine CJ; WISE Investigators.

    J Womens Health (Larchmt). 2008 Sep;17(7):1081-92.PMID: 18774893 [PubMed - indexed for MEDLINE]Related articles

    19.

    Provoked coronary spasm and acute coronary syndromes.

    Pepine CJ.

    J Am Coll Cardiol. 2008 Aug 12;52(7):528-30. No abstract available. PMID: 18687245 [PubMed - indexed for MEDLINE]Related articles

    20.

    Alpha-adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES).

    Gerhard T, Gong Y, Beitelshees AL, Mao X, Lobmeyer MT, Cooper-DeHoff RM, Langaee TY, Schork NJ, Shriver MD, Pepine CJ, Johnson JA; INVEST Investigators.

    Am Heart J. 2008 Aug;156(2):397-404. Epub 2008 Jun 20.PMID: 18657677 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.

    Bangalore S, Messerli FH, Cohen JD, Bacher PH, Sleight P, Mancia G, Kowey P, Zhou Q, Champion A, Pepine CJ; INVEST Investigators.

    Am Heart J. 2008 Aug;156(2):241-7.PMID: 18657652 [PubMed - indexed for MEDLINE]Related articles

    22.

    Postmarket evaluation of breakthrough technologies.

    Rao SV, Califf RM, Kramer JM, Peterson ED, Gross TP, Pepine CJ, Williams DO, Donohoe D, Waksman R, Mehran R, Krucoff MW.

    Am Heart J. 2008 Aug;156(2):201-8.PMID: 18657647 [PubMed - indexed for MEDLINE]Related articles

    23.

    beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension.

    Pacanowski MA, Gong Y, Cooper-Dehoff RM, Schork NJ, Shriver MD, Langaee TY, Pepine CJ, Johnson JA; INVEST Investigators.

    Clin Pharmacol Ther. 2008 Dec;84(6):715-21. Epub 2008 Jul 9.PMID: 18615004 [PubMed - indexed for MEDLINE]Related articles

    24.

    Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST).

    Kolloch R, Legler UF, Champion A, Cooper-Dehoff RM, Handberg E, Zhou Q, Pepine CJ.

    Eur Heart J. 2008 May;29(10):1327-34. Epub 2008 Mar 29.PMID: 18375982 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Marrow cell therapies for cardiovascular diseases.

    Cogle CR, Madlambayan GJ, Hubsher G, Beckman C, Speisman R, Tran-Son-Tay R, Pepine CJ.

    Exp Hematol. 2008 Jun;36(6):687-94. Epub 2008 Apr 2. Review.PMID: 18375038 [PubMed - indexed for MEDLINE]Related articles

    26.

    Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.

    Pacanowski MA, Zineh I, Li H, Johnson BD, Cooper-DeHoff RM, Bittner V, McNamara DM, Sharaf BL, Merz CN, Pepine CJ, Johnson JA.

    J Transl Med. 2008 Mar 10;6:11.PMID: 18331634 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Clinical and research issues regarding chronic advanced coronary artery disease: part I: Contemporary and emerging therapies.

    Jolicoeur EM, Granger CB, Henry TD, Holmes DJ, Pepine CJ, Mark D, Chaitman BR, Gersh BJ, Ohman EM; Working Group Members.

    Am Heart J. 2008 Mar;155(3):418-34. Epub 2008 Jan 31. Review.PMID: 18294474 [PubMed - indexed for MEDLINE]Related articles

    28.

    Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation.

    Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, Kelsey SF, Kip KE, Cooper-Dehoff RM, Johnson BD, Vaccarino V, Reis SE, Bittner V, Hodgson TK, Rogers W, Pepine CJ.

    J Clin Endocrinol Metab. 2008 Apr;93(4):1276-84. Epub 2008 Jan 8.PMID: 18182456 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Predicting stroke risk in hypertensive patients with coronary artery disease: a report from the INVEST.

    Coca A, Messerli FH, Benetos A, Zhou Q, Champion A, Cooper-DeHoff RM, Pepine CJ.

    Stroke. 2008 Feb;39(2):343-8. Epub 2007 Dec 27.PMID: 18162623 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Symptom presentation of women with acute coronary syndromes: myth vs reality.

    Canto JG, Goldberg RJ, Hand MM, Bonow RO, Sopko G, Pepine CJ, Long T.

    Arch Intern Med. 2007 Dec 10;167(22):2405-13. Review.PMID: 18071161 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Blood pressure targets after high-risk myocardial infarction: is it time to update the guidelines?

    Denardo SJ, Anderson RD, Pepine CJ.

    Hypertension. 2008 Jan;51(1):26-7. Epub 2007 Nov 26. No abstract available. PMID: 18039982 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    The editor's roundtable: chronic stable angina pectoris.

    Friedewald VE, King SB 3rd, Pepine CJ, Vetrovec GW, Roberts WC.

    Am J Cardiol. 2007 Dec 1;100(11):1635-43. Epub 2007 Oct 25. No abstract available. PMID: 18036361 [PubMed - indexed for MEDLINE]Related articles

    33.

    Obesity paradox in patients with hypertension and coronary artery disease.

    Uretsky S, Messerli FH, Bangalore S, Champion A, Cooper-Dehoff RM, Zhou Q, Pepine CJ.

    Am J Med. 2007 Oct;120(10):863-70.PMID: 17904457 [PubMed - indexed for MEDLINE]Related articles

    34.

    Speed, cocaine, and other psychostimulants death rates.

    Gold MS, Graham NA, Kobeissy FH, Pepine CJ, Goldberger BA.

    Am J Cardiol. 2007 Oct 1;100(7):1184. Epub 2007 Jun 8. No abstract available. PMID: 17884386 [PubMed - indexed for MEDLINE]Related articles

    35.

    KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST).

    Beitelshees AL, Gong Y, Wang D, Schork NJ, Cooper-Dehoff RM, Langaee TY, Shriver MD, Sadee W, Knot HJ, Pepine CJ, Johnson JA; INVEST Investigators.

    Pharmacogenet Genomics. 2007 Sep;17(9):719-29.PMID: 17700361 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Cardiovascular protection using beta-blockers: a critical review of the evidence.

    Bangalore S, Messerli FH, Kostis JB, Pepine CJ.

    J Am Coll Cardiol. 2007 Aug 14;50(7):563-72. Epub 2007 Jul 30. Review.PMID: 17692739 [PubMed - indexed for MEDLINE]Related articles

    37.

    Influence of Hispanic ethnicity on blood pressure control and cardiovascular outcomes in women with CAD and hypertension: findings from INVEST.

    Cooper-DeHoff RM, Zhou Q, Gaxiola E, Cangiano JL, Garcia-Barreto D, Handberg E, Pepine CJ; INVEST Investigators.

    J Womens Health (Larchmt). 2007 Jun;16(5):632-40.PMID: 17627399 [PubMed - indexed for MEDLINE]Related articles

    38.

    Metabolic syndrome and cardiovascular disease: challenges and opportunities.

    Cooper-DeHoff RM, Pepine CJ.

    Clin Cardiol. 2007 Dec;30(12):593-7. Review.PMID: 17607758 [PubMed - indexed for MEDLINE]Related articles

    39.

    Blood pressure control and improved cardiovascular outcomes in the International Verapamil SR-Trandolapril Study.

    Mancia G, Messerli F, Bakris G, Zhou Q, Champion A, Pepine CJ.

    Hypertension. 2007 Aug;50(2):299-305. Epub 2007 Jul 2.PMID: 17606861 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SR.

    Messerli F, Frishman WH, Elliott WJ, Bacher PH, Pepine CJ.

    Blood Press Suppl. 2007 Mar;1:6-9.PMID: 17566313 [PubMed - indexed for MEDLINE]Related articles

    41.

    Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study).

    Brunner M, Cooper-DeHoff RM, Gong Y, Karnes JH, Langaee TY, Pepine CJ, Johnson JA; INVEST Investigators.

    Am J Cardiol. 2007 Jun 1;99(11):1549-54. Epub 2007 Apr 16.PMID: 17531579 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Phytoestrogens and coronary microvascular function in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE) Study.

    Pepine CJ, von Mering GO, Kerensky RA, Johnson BD, McGorray SP, Kelsey SF, Pohost G, Rogers WJ, Reis SE, Sopko G, Bairey Merz CN; WISE Study Group.

    J Womens Health (Larchmt). 2007 May;16(4):481-8.PMID: 17521251 [PubMed - indexed for MEDLINE]Related articles

    43.

    ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases.

    Mensah GA, Grant AO, Pepine CJ.

    J Am Coll Cardiol. 2007 Mar 27;49(12):1376-9. No abstract available. PMID: 17394978 [PubMed - indexed for MEDLINE]Related articles

    44.

    ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases.

    Mensah GA, Grant AO, Pepine CJ, Baddour LM, Cooper LT Jr, Dunbar SB, Froelicher ES, Greenlund KJ, Kaplan EL, Kloner RA, Labarthe DR, Luepker RV, Madjid M, Muller JE, O'Connor S, Ornato JP, Robertson RM, Roy MJ, Shah PK, Taubert KA, Wilson WR, Zheng ZJ, Harrington RA, Abrams J, Anderson JL, Bates ER, Eisenberg MJ, Grines CL, Hlatky MA, Lichtenberg RC, Lindner JR, Pohost GM, Schofield RS, Shubrooks SJ Jr, Stein JH, Tracy CM, Vogel RA, Wesley DJ.

    J Am Coll Cardiol. 2007 Mar 27;49(12):1373-412. No abstract available. PMID: 17394977 [PubMed - indexed for MEDLINE]Related articles

    45.

    Blood pressure levels on progression of coronary atherosclerosis.

    Messerli FH, Mancia G, Conti CR, Pepine CJ.

    J Am Coll Cardiol. 2007 Mar 27;49(12):1369; author reply 1369-70. Epub 2007 Mar 9. No abstract available. PMID: 17394972 [PubMed - indexed for MEDLINE]Related articles

    46.

    ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases.

    Mensah GA, Grant AO, Pepine CJ, Baddour LM, Cooper LT Jr, Dunbar SB, Froelicher ES, Greenlund KJ, Kaplan EL, Kloner RA, Labarthe DR, Luepker RV, Madjid M, Muller JE, O'Connor S, Ornato JP, Robertson RM, Roy MJ, Shah PK, Taubert KA, Wilson WR, Zheng ZJ, Harrington RA, Abrams J, Anderson JL, Bates ER, Eisenberg MJ, Grines CL, Hlatky MA, Lichtenberg RC, Lindner JR, Pohost GM, Schofield RS, Shubrooks SJ Jr, Stein JH, Tracy CM, Vogel RA, Wesley DJ.

    Circulation. 2007 Mar 27;115(12):1656-95. Epub 2007 Mar 19. No abstract available. PMID: 17372165 [PubMed - indexed for MEDLINE]Related articles

    47.

    ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases.

    Mensah GA, Grant AO, Pepine CJ.

    Circulation. 2007 Mar 27;115(12):1659-62. Epub 2007 Mar 19. No abstract available. PMID: 17372164 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Association of CYP3A5 polymorphisms with hypertension and antihypertensive response to verapamil.

    Langaee TY, Gong Y, Yarandi HN, Katz DA, Cooper-DeHoff RM, Pepine CJ, Johnson JA.

    Clin Pharmacol Ther. 2007 Mar;81(3):386-91.PMID: 17339868 [PubMed - indexed for MEDLINE]Related articles

    49.

    Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE).

    Wessel TR, Arant CB, McGorray SP, Sharaf BL, Reis SE, Kerensky RA, von Mering GO, Smith KM, Pauly DF, Handberg EM, Mankad S, Olson MB, Johnson BD, Merz CN, Sopko G, Pepine CJ; NHLBI Women's Ischemia Syndrome Evaluation (WISE).

    Clin Cardiol. 2007 Feb;30(2):69-74.PMID: 17326061 [PubMed - indexed for MEDLINE]Related articles

    50.

    Raising awareness of angina in women.

    Gruen LM, Pepine CJ.

    Heart. 2007 Mar;93(3):279-80.PMID: 17322502 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...